SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 273 filers reported holding SEATTLE GENETICS INC in Q4 2016. The put-call ratio across all filers is 2.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $28,000 | 0.0% | 406 | +4.6% | 0.01% | 0.0% |
| Q1 2019 | $28,000 | +27.3% | 388 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $22,000 | -31.2% | 388 | -5.6% | 0.01% | -9.1% |
| Q3 2018 | $32,000 | +18.5% | 411 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $27,000 | +58.8% | 411 | +24.9% | 0.01% | +120.0% |
| Q1 2018 | $17,000 | +325.0% | 329 | +376.8% | 0.01% | +400.0% |
| Q4 2017 | $4,000 | +300.0% | 69 | +228.6% | 0.00% | – |
| Q3 2017 | $1,000 | -85.7% | 21 | -84.7% | 0.00% | -100.0% |
| Q2 2017 | $7,000 | +133.3% | 137 | +242.5% | 0.00% | +200.0% |
| Q1 2017 | $3,000 | +200.0% | 40 | +90.5% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 21 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $1,000 | 0.0% | 21 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |